Wanted terrorist Tunda arrested

August 17, 2013

Wanted_terroristNew Delhi, Aug 17: One of India's most wanted terrorist, Syed Abdul Karim alias Tunda, accused of masterminding over 40 bombings in the country, has been arrested by Delhi Police from the Indo-Nepal border after he was apparently deported from one of the Gulf countries.

70-year-old Tunda, an expert bomb maker of terror outfit Lashkar-e-Toiba, would be produced before a court by Delhi Police later today, official sources said.

Describing Tunda as a major catch, the security agencies say he would be able to throw some light on Lashkar-e-Taiba's operations in India.

The details about his arrest were sketchy but Tunda, against whom an Interpol Red Corner notice was issued in 1996, was apparently deported from one of the Gulf countries and his arrest was effected at the Indo-Nepal border.

A resident of Pikhuwa in Uttar Pradesh's Ghaziabad district, Tunda was one of the 20 terrorists whose extradition India had demanded from Pakistan after the 2001 attack on Parliament House. This list included Lashkar chief Hafiz Mohammad Saeed and his Jaish-e-Mohammad counterpart Maulana Azhar Masood Alvi.

The CBI had charged Karim with organising LeT's major terror attacks outside of Jammu and Kashmir — a series of 43 bombings in Mumbai, Hyderabad, Delhi, Rohtak and Jalandhar in which over 20 persons were killed and over 400 injured.

He had also triggered explosions on inter-city trains on December 6, 1993 that claimed two lives.

Besides being an expert in bomb making, Tunda had a major hand in spreading Laskhar-e-Taiba's network outside Jammu and Kashmir.

Before joining the ranks of the terror outfit, he ran a homoeopathic shop in the early 1980's.

The sources say that though he was not directly involved in perpetrating bombings after 1998, he acted as mentor for a younger generation of Lashkar operatives, financing and organising operations across India.

He was known as Tunda (handicapped) after he lost his left hand in a bomb-making accident.

Many stories had been floated earlier about his whereabouts and the hunt for him virtually ended at one point when it was believed that he had been killed in a blast in Bangladesh.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 26,2020

Jun 26: The Supreme Court on Friday permitted the Centre and the CBSE to cancel the remaining board examinations due to the COVID-19 pandemic and gave the go-ahead for the scheme to award marks to students for the cancelled papers scheduled to be held in July.

A bench of Justices A M Khanwilkar, Dinesh Maheshwari and Sanjiv Khanna permitted the CBSE to issue a notification for the cancellation of the examinations.

Solicitor General Tushar Mehta, appearing for the Centre and the CBSE, said that the assessment scheme would consider marks scored by students in the last three papers of the board exams.

Both CBSE and ICSE told the top court that the results of the class X and XII board exams can be declared by the middle of July.

The top court was hearing pleas seeking relief, including scrapping of remaining exams of Class 12 scheduled from July 1 to 15, in view of increasing number of COVID-19 cases. Similar relief was sought by the ICSE Board also.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 8,2020

Jaipur, Jun 8: An inquiry has been initiated against staff of a private hospital in Rajasthan's Churu district after receiving screenshots of a purported WhatsApp chat in which they allegedly discussed about not attending to Muslim patients affected by COVID-19, police said on Sunday.

Screenshots of the chat between the hospital staff had gone viral following which an investigation has been initiated, they said.

Dr Sunil Choudhary, who runs the Srichand Baradiya Rog Nidan Kendra in Sardarshahar and whose staff purportedly wrote the messages, apologised through a Facebook post, saying the hospital staff did not have any intention to hurt any religious groups.

"We have received a complaint following which we are taking action to register FIR in the matter," Churu Superintendent of Police Tejaswini Gautam said.

Sardarshahar police station SHO Mahendra Dutt Sharma said the police control room had received a complaint regarding screenshots of the chat being circulated on social media. "We are inquiring into the matter. An FIR will be registered against the names mentioned in the WhatsApp chat," Sharma said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.